One notable exception was fibroblast growth factor 21 (FGF-21), elevated levels of which were associated with a higher risk of colorectal cancer in the Swedish study, in which both the discovery and validation phases used pre-diagnostic samples [47], and in the BliTz validation set [48]. Here, FGF21 is linked to colorectal cancer.